A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor

Leukemia and Lymphoma

Volumn 25, Issue 3-4, 1997, Pages 257-270

  Bendel, Anne E ^a   Shao, Yu ^a   Davies, Stella M ^a   Warman, Berta ^a   Yang, Chang H ^a   Waddick, Kevin G ^a   Uckun, Fatih M ^a   Perentesis, John P ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diphtheria toxin GM CSF fusion toxin; GM CSF receptor; Myeloid leukemia

Indexed keywords

ANTILEUKEMIC AGENT; CELL SURFACE RECEPTOR; CYTOKINE RECEPTOR; DIPHTHERIA TOXIN; ELONGATION FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; RECOMBINANT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BLAST CELL; BONE MARROW CELL; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; GENETIC ENGINEERING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR AFFINITY;

EID: 0030913706     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709114165     Document Type: Article

References (56)

1. Sandler, D. P. (1987). Epidemiology of acute myelogenous leukemia, Seminars in Oncology, 14, 359-364.
2. Rohatiner, A. and Lister, T. A. (1996) Acute Myelogenous Leukemia in Adults. In Leukemia, 6th Edition., edited by E. S. Henderson, T. A. Lister and M. F. Greaves, pp. 479-508. Philadelphia: W. B. Saunders.
3. Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Ahlgren, L. T., Chelstrom, L. M., Burkhardt, A., Bolen, J. and Myers, D. E. (1995). Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases, Science, 267, 886-891.
4. Pastan, I., and FitzGerald, D. (1991). Recombinant toxins for cancer treatment, Science, 254, 1173-1177.
5. Vitetta, E. S. and Thorpe, P. E. (1991). Antibodies in cancer therapy Basic principles of monoclonal antibodies. Section 21.2. Immunotoxins. In Biologic Therapy of Cancer edited By V. T. Devita, S. Hellman, S., S. A. Rosenberg, pp. 48-85. Philadelphia, PA; J.B. Lippincott Company.
6. Perentesis, J. P. and Kersey, J. H. (1996). Biologic Therapy of Leukemia In Leukemia, 6th Edition., edited by E. S. Henderson, T. A. Lister and M. F. Greaves, pp. 354-388. Philadelphia: W. B. Saunders.
7. Young, D. C. and Griffin, J. D. (1988). Autocrine secretion of GM-CSF in acute myeloblastic leukemia, Blood, 68, 1178-1181.
8. Cheng, G. Y. M., Kelleher, C. A., Miyauchi, J., Wang, C., Wong, G., Clark, S. C., McCulloch, E. A. and Minden, M. D. (1988). Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia, Blood, 71, 204-208.
9. Murohashi, I., Tonda, S., Susuki, T., Nazata, K., Yamashita, Y. and Nara, N. (1989). Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia, Blood, 74, 35-41.
10. Russell, N. H. (1992) Autocrine growth factors and leukaemic haemopoiesis, Blood Reviews, 6, 149-156.
11. Bradbury, D., Rogers, S., Kozlowski, R., Bowen, G., Reilly, I. A. G., Russell, N. H. (1990) Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia. British Journal of Haematology, 76, 488-93.
12. Bradbury, D., Rogers, S., Reilly, I. A. G., Kozlowski, R., Russell, N. H. (1992). Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1-beta in the autonomous growth of acute myeloblastic leukemia cells - studies using purified CD34-postive cells, Leukemia, 6, 562-66.
13. Rogers, S. Y., Bradbury, D., Kozlowski, R., Russell, N. H. (1994). Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells, Experimental Hematology, 22, 593-598.
14. Löwenberg, B., van Putten, W. L. J., Touw, I. P., Delwel, R. and Santini, V. (1993). Autonomous growth determines prognosis in adult acute myeloid leukemia, New England Journal of Medicine, 328, 614-619.
15. Hunter, A. E., Rogers, S. Y., Roberts, I. A. G., Barrett, A. J. and Russell, N. (1993) Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia, Blood, 82, 899-903.
16. Yamaizumi, J., Mekada, E., Uchida, T., Okada, Y. (1978). One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell, Cell, 15, 245-250.
17. Perentesis, J. P., Miller, S. P. and Bodley, J. W. (1992). Protein toxin inhibitors of protein synthesis, Biofactors, 3, 173-184.
18. Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M. G., Kantafdjieff, K. A., Collier, R. J., Eisenberg, D. (1992). The crystal structure of diphtheria toxin, Nature, 357, 216-222.
19. Bennett, M. J., Choe, S., Eisenberg, D. (1994). Domain swapping: Entangling alliances between proteins. Proceedings of the National Academy of Sciences, USA, 91, 3127-3131.
20. Williams, D. P., Parker, K., Bacha, P., Bishai, W., Borowski, M., Genbauffe, F., Strom, T. B., Murphy, J. R. (1987). Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein, Protein Engineering, 1, 493-498.
21. Jean, L. F., Murphy, J. R. (1991). Diphtheria toxin receptor-binding domain substitution with interleukin 6. Genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein, Protein Engineering, 4, 989-994.
22. Lakkis, F., Steele, A., Pacheco-Silva, A., Rubin-Kelley, V., Strom, T. B. and Murphy, J. R. (1991). Interleukin 4 receptor targeted cytotoxicity: Genetic construction and in vivo immunosuppresive activity of a diphtheria toxin-related murine interleukin 4 fusion protein, European Journal of Immunology, 21, 2253-2258.
23. Shaw, J. P., Akiyoshi, D. E., Arrigo, D. A., Rhoad, A. E., Sullivan, B., Thomas, J., Genbauffe, F. G., Bacha, P. and Nichols, J. C. (1991). Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins, Journal of Biological Chemistry, 266, 21118-21124.
24. LeMaistre, C. F., Meneghetti, C., Rosenblum, M., Reuben, J., Parker, K., Shaw, J., Deisseroth, A., Woodworth, T., Parkinson, D. R. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor, Blood, 79, 2547-2554.
25. LeMaistre, C. F., Craig, F. E., Meneghetti, C., McMullin, B., Parker, K., Reuben, J., Boldt, D. H., Rosenblum, M., Woodworth, T. (1993). Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematologic cancers, Cancer Research, 53, 3930-3934.
26. Waters, C. A., Schimke, P. A., Snider, C. E., Strom, T. B., Murphy, J. R. (1990). Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells, European Journal of Immunology, 20, 785-791.
27. Bacha, P., Williams, D. P., Waters. C., Murphy, J. R., Strom, T. B. (1988). Interleukin-2 receptor cytotoxicity Interleukin-2 receptor mediated action of a diphtheria toxin-related interleuin-2 fusion protein, Journal of Experimental Medicine, 167, 612-622.
28. Woodworth, T. G. and Nichols, J. C. (1993). Recombinant fusion toxins - a new class of targeted biologic therapeutics, Cancer Treatment & Research, 68, 145-160.
29. Perentesis, J. P., Genbauffe, F. S., Veldman, S. A., Galeotti, C. L., Livingston, D. M., Bodley, J. W., Murphy, J. R. (1988). Expression of diphtheria toxin fragment A and hormone-toxin fusion proteins in toxin-resistant yeast mutants, Proceedings of the National Academy of Sciences, USA, 85, 8386-8390.
30. Sambrook, J., Maniatis, T. and Fritsch, E. S. (1989). Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
31. Chen, J., Bodley, J. W., Livingston, D. M. (1985). Diphtheria toxin-resistant mutants of Saccharomyces cerevisiae, Molecular and Cellular Biology, 5, 3375-3360.
32. Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y-F., Miyazono, K., Urabe, A., Takaku, F. (1989). Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin, Journal of Cellular Physiology, 140, 323-334.
33. Collins, S. J. (1987). The HL-60 promyelocytic leukemia cell line Proliferation, differentiation, and cellular oncogene expression, Blood, 70, 1233-1244.
34. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., Tada, K. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), International Journal of Cancer, 26, 171-176.
35. Lange, B. M., Valtieri, M., Santoli, D., Caracciolo, D., Mavilio, F., Gemmperlein, I., Griffin, C., Emanuel, B., Finan, J., Nowell, P., Rovera, G. (1987). Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines, Blood, 70, 192-199.
36. Stong, R. C., Korsmeyer, S. J., Parkin, J. L., Arthur, D. C., Kersey, J. H. (1985). Human acute leukemia cell line with the t(4:11) chromosomal rearrangement exhibits B lineage and monocytic characteristics, Blood, 65, 21-31.
37. Lozzio, C. B., Lozzio, B. B. (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome, Blood, 45, 321-324.
38. Uckun, F. M., Mitchell, J. B., Obuz, V., Park, C. H., Waddick, K., Friedman, N., Oubaha, L., Min, W. S., Song, C. W. (1991). Radiation sensitivity of human B-lineage lymphoid precursor cells, International Journal of Radiation Oncology Biology and Physics, 21, 1553-1560.
39. Holmes, K. L., Palaszynski, E., Fredrickson, T. N., Morse, H. C. III, Ihle, J. (1985). Correlation of cell-surface phenotype with the establishemnt of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms, Proceedings of the National Academy of Sciences, USA, 82, 6687-6691.
40. Mosmann, T. (1983). Rapid colorimetric assay for cellular grow th and survival. Application to proliferation and cytotoxicity assays, Journal of Immunologic Methods, 65, 55-63.
41. Uckun, F. M., Ramakrishnan, S., Houston, L. L. (1985). Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell -specific immunotoxin containing poke-weed antiviral protein, Cancer Research, 45, 69-75.
42. Uckun, F. M., Ramakrishnan, S., Houston, L. L. (1985) Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow, Journal of Immunology, 134, 2010-16.
43. Uckun, F. M., Stong, R. C., Youle, R. J., Vallera, D. A. (1985). Combined ex vivo treatment with immunotoxins and mafosfamid: A novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts, Journal of Immunology, 134, 3504-3515.
44. Oval, J., Taetle, R. (1990) Factor-dependent human leukemia cell lines: New models for regulation of acute non-lymphocytic leukemia cell growth and differentiation, Blood Reviews, 4, 270-279.
45. Naglich, J. G., Metherall, J. E., Russell, D. W., Eidels, L. (1992). Expresson cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor, Cell, 69, 1051-1061.
46. Diederichs, K., Boone, T., Karplus, P. A. (1991). Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor, Science, 254, 1779-1782.
47. Walter, M. R., Cook, W. J., Ealick, S. E., Nagabhushan, T. L., Trotta, P. P., Bugg, C. E. (1992). Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor, Journal of Molecular Biology, 224, 1075-1085.
48. Bazan, J. P. (1990). Structural design and molecular evolution of a cytokine receptor superfamily, Proceedings of the National Academy of Sciences, USA, 87, 6934-6938.
49. Metcalf, D. (1993). Hematopoietic regulators: Redundancy or sublety? Blood, 82, 3515-23.
50. Gasson, J. C. (1991). Molecular Physiology of granulocyte-macrophage colony-stimulating factor, Blood, 77, 1131-1145.
51. Clark, S. C. and Kamen, R. (1987). The human hematopoietic colony-stimulating factors, Science, 236, 1229-1237.
52. Miyajima, A., Mui, A. L-F., Ogorochi, T. et al. (1993). Receptors for granulocyte-macrophage colony stimulating factor, interleukin-3, and interleukin-5, Blood, 82, 1960-1974.
53. Berardi, A. C., Wang, A., Levine, J. D., Lopez, P., Scadden, D. T. (1995) Functional isolation and characterization of human hematopoietic stem cells, Science, 267, 104-108.
54. Spielholz, C., Heaney, M. L., Morrison, M. E., Houghton, A. N., Carlos Vera, J., Golde, D. W. (1995). Granulocyte-macrophage colony-stimulating factor signals for increased glucose uptake in human melanoma cells, Blood, 85, 973-980.
55. Baldwin, G. C., Gasson, J. C., Kautman, S. E., Quan, S. G., Williams, R. E., Avalos, B. R., Gazdar, A. F., Golde, D. D. W., DiPersio, J. F. (1989). Nonhematopoietic tumor cells express functional GM-CSF receptors, Blood, 73, 1033-1037.
56. Berdel, W. E., Danhauser-Riedl, S., Steinhauser, G., Winton, E. F. (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells, Blood, 73, 80-83.